CPT code 20250 represents an open biopsy of the thoracic vertebral body, a surgical diagnostic procedure used to obtain tissue when malignancy or spinal infection (for example, osteomyelitis) is suspected. Nationally, this code is relevant to hospitals and surgical centers involved in spine care and oncologic or infectious disease diagnosis because it carries implications for surgical resource use, perioperative management, and downstream pathology services.

Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for the procedure, typical sites of service, and the service type. The publication outlines common billing and documentation considerations tied to open vertebral biopsy coding, summarizes expected utilization benchmarks where available, and highlights policy and coverage themes that affect authorization and payment processes for spine biopsy procedures.

This summary is intended for coding professionals, hospital revenue-cycle staff, and clinical leaders seeking a national view of how CPT code 20250 is used and reimbursed, and what operational and policy factors commonly influence billing for thoracic vertebral body open biopsies.